Sickle Cell Disease Study – Site of Dr. Kaali News / August 11, 2021 MCT is pleased to announce the recruitment of the first patients at Kintampo site in Ghana, on a promising SCD study. Thanks to Dr. Kaali…
MCT’s collaboration with Onxeo on HCC Phase III study in Middle East News / March 26, 2015 Onxeo has engaged MCT (Regional CRO specialized on Middle East and Africa) to expand “Relieve” phase III HCC study in 3 Middle East countries (Lebanon,…
